| 000 | 01576 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516210837.0 | ||
| 264 | 0 | _c20140912 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-014-2049-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeux, Christophe | |
| 245 | 0 | 0 |
_aMantle cell lymphoma epidemiology: a population-based study in France. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cAug 2014 |
||
| 300 |
_a1327-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Distribution |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aSex Distribution |
| 700 | 1 | _aMaynadié, Marc | |
| 700 | 1 | _aTroussard, Xavier | |
| 700 | 1 | _aCabrera, Quentin | |
| 700 | 1 | _aHerry, Aurélie | |
| 700 | 1 | _aLe Guyader-Peyrou, Sandra | |
| 700 | 1 | _aLe Gouill, Steven | |
| 700 | 1 | _aMonnereau, Alain | |
| 773 | 0 |
_tAnnals of hematology _gvol. 93 _gno. 8 _gp. 1327-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-014-2049-5 _zAvailable from publisher's website |
| 999 |
_c23766743 _d23766743 |
||